Myelomastocytic Blast Cell Crisis in Resistant Tyrosine Kinase Inhibitor Chronic Myelogenous Leukemia: Case Report and Review of Literature

We present the clinical case of a 29-year-old male with a diagnosis of chronic myeloid leukemia (CML) in high-risk chronic phase since February 2010. He started treatment with imatinib at a dose of 400 mg obtaining a hematologic response early but without reaching a cytogenetic response in month 18....

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Cordero, Humberto, Patiño-Escobar, Bonell, Enciso, Leonardo J, Otero, Diana M, Spirko, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561613/
https://www.ncbi.nlm.nih.gov/pubmed/31223555
http://dx.doi.org/10.7759/cureus.4703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561613/
https://www.ncbi.nlm.nih.gov/pubmed/31223555
http://dx.doi.org/10.7759/cureus.4703

Ejemplares similares